new_0222_0497|MIRM|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0497|MIRM|Long Name|1|1|Mirum Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Mirum Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Mirum Pharmaceuticals Inc Inventories (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Mirum Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Mirum Pharmaceuticals Inc Book Value (Quarterly) (USD)|Mirum Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Mirum Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc EV to Revenues|Mirum Pharmaceuticals Inc EV to Earnings|Mirum Pharmaceuticals Inc EV to Free Cash Flow|Mirum Pharmaceuticals Inc EV to Assets (Quarterly)|Mirum Pharmaceuticals Inc PS Ratio|Mirum Pharmaceuticals Inc PE Ratio|Mirum Pharmaceuticals Inc Price to Book Value|Mirum Pharmaceuticals Inc PEG Ratio|Mirum Pharmaceuticals Inc Debt to Equity Ratio|Mirum Pharmaceuticals Inc Dividend Yield|Mirum Pharmaceuticals Inc Shareholder Yield (TTM)|Mirum Pharmaceuticals Inc Percent of Shares Outstanding Short|Mirum Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc Return on Invested Capital|Mirum Pharmaceuticals Inc Quality Ratio Score|Mirum Pharmaceuticals Inc Momentum Score|Mirum Pharmaceuticals Inc Beta (1Y)|Mirum Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Mirum Pharmaceuticals Inc Institutional Investor Ownership Percentage|Mirum Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Mirum Pharmaceuticals Inc Total Employees (Annual)|Mirum Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Mirum Pharmaceuticals Inc Shares Outstanding|Mirum Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Mirum Pharmaceuticals Inc Payout Ratio|Mirum Pharmaceuticals Inc Quick Ratio (Quarterly)|Mirum Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Mirum Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Mirum Pharmaceuticals Inc Effective Tax Rate (TTM)|Mirum Pharmaceuticals Inc Return on Equity|Mirum Pharmaceuticals Inc Net Income (TTM) (USD)|Mirum Pharmaceuticals Inc Revenue (TTM) (USD)|Mirum Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Mirum Pharmaceuticals Inc Revenue (Quarterly) (USD)|Mirum Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Mirum Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Mirum Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Price (USD)|Mirum Pharmaceuticals Inc Total Return Price (USD)|Mirum Pharmaceuticals Inc Enterprise Value (USD)|Mirum Pharmaceuticals Inc 30-Day Average Daily Volume|Mirum Pharmaceuticals Inc 1 Year Price Returns (Daily)
new_0222_0497|MIRM|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0497|MIRM||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0497|MIRM||5|5|91.4|91.4|0|91.4|0|91.4|91.4|91.4|0|91.4|91.4|0|0|0|1.44795539033|92|0|0|1.44610281924|0|92|1.4471669219|0|15.25|0|91.4|91.4|0|0|32.375|30.5|0|0|99.6363636364|85.3|99.6363636364|31.5555555556|0|91.4|0|92|99.6363636364|91.4|91.2857142857|0|91.375|0|0|92|0|99.6363636364|99.6363636364|99.6363636364|99.6363636364|6.95588235294|6.95588235294|6.94852941176|1.44871794872|1.4425
new_0222_0497|MIRM||6|6|10|10|0|10|0|10|10|10|0|10|10|0|0|0|538|1|0|0|603|0|1|653|0|60|0|10|10|0|0|16|18|0|0|11|10|11|27|0|10|0|1|11|10|7|0|8|0|0|1|0|11|11|11|11|136|136|136|624|400
new_0222_0497|MIRM||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0497|MIRM|201809|201809|201809||||||||||||||||||||||||||||||||||10.0063||-0.0067||||||-0.0067|||||||||0.062|-0.067|-0.067|-0.002|||||
new_0222_0497|MIRM|201903|201903|201903|49.756|49.493||1.317||67.562|6.523|61.039||-16.062|-23.305|||||||||||||||2.375|6.991|||||||10.0063||-0.5953|||23.0158|||-0.5953|0||||||||1.321|-5.957|-5.957|0.232|||||
new_0222_0497|MIRM|201905|201903|201903|||||||||||||||||||||||||||||||||||24||||||||||||||||||||||||
new_0222_0497|MIRM|201906|201906|201906|84.858|84.192||1.429||132.216|11.108|121.108||-27.95|-36.862|||||||||||||||2.348|6.991|||||||23.0158|25|-0.589|||23.0158|||-0.589|0||||||||2.445|-13.557|-13.557|0.468|||||
new_0222_0497|MIRM|201907|201906|201906||||||||||||||||||||||0||0.2554|||||||||||||23.0158||||||||||||||||||13.78|13.78|232.9657||
new_0222_0497|MIRM|201908|201906|201906||||||||||||||||||||||0||0.556|||||||||||||22.99||||||||||||||||||12.88|12.88|211.9192|60126.7667|
new_0222_0497|MIRM|201909|201909|201909|129.317|126.259||1.572||12.07|10.909|1.161||146.203|-51.949||||||||1.5528|||0||0.1682||2.665|0.002|||||||17.9961|29|-0.84|22.5669||22.5669|||-0.84|-67.2|||-34.668|||||3.708|-15.087|-15.087|0.785|9.61|9.61|136.7419|47863.8667|
new_0222_0497|MIRM|201910|201909|201909|||||||||||||||||||1.1083|||0||0.4505|||||||||||||||||||||||||||||||7.18|7.18|35.7713|33084.8|
new_0222_0497|MIRM|201911|201909|201909|||||||||||||||||||1.1338|||0||0.4225|||||||||||||22.5892||||||||||||||||||7.42|7.42|44.3268|59234.1333|
new_0222_0497|MIRM|201912|201912|201912|119.363|116.66||3.733||16.363|13.076|3.287||130.349|-69.901||||-11.036||||4.2514|||0||1.1895||3.351|0.002|||||||22.6003|33|-0.79|22.6003||22.6003|||-0.79|0|-0.04||-52.553|||||4.278|-17.931|-17.952|0.747|25.18|25.18|442.5371|613631.8|
new_0222_0497|MIRM|202001|201912|201912|||||||||||||||-6.974||||3.016|||0||1.9202|||||||||||||25.0003||||||||||||||||||16.87|16.87|305.0951|380640.3333|
new_0222_0497|MIRM|202002|201912|201912|||||||||||||||-7.5006||||3.1761|||0||2.5812|||||||||||||||||||||||||||||||15.79|15.79|278.0947|107276.3|
new_0222_0497|MIRM|202003|202003|202003|162.436|159.531||3.677||16.685|13.548|3.137||156.118|-91.211||||-3.4328||||2.2449|||0||2.0977||3.265|0.003|||||||24.7047|41|-0.86|25.0337||25.0337|||-0.86|-44.659|-0.0368||-67.906|||||4.692|-21.306|-21.31|0.749|13.99|13.99|233.0942|84963.8333|
new_0222_0497|MIRM|202004|202003|202003|||||||||||||||-4.738||||2.7099|||0||2.138|||||||||||||25.0337||||||||||||||||||16.9|16.9|263.5385|50041.4333|
new_0222_0497|MIRM|202005|202003|202003|||||||||||||||-4.8235||||2.7404|||0||2.1276|||||||||||||25.39||||||||||||||||||16.74|16.74|265.4976|64933.3|
new_0222_0497|MIRM|202006|202006|202006|152.075|149.336||3.53||19.558|16.58|2.978||136.208|-114.462||||-5.2365||||3.5819|||0||2.5439||3.024|0.003|||||||25.0561|54|-0.93|25.0713||25.0713|||-0.93|-0.025|-0.0361||-77.6|||||5.042|-23.248|-23.251|0.405|20.8|20.8|368.581|128379.8333|
new_0222_0497|MIRM|202007|202006|202006|||||||||||||||-6.3645||||4.1173|||0||2.3911|||||||2.0404||||||25.3991||||||||||||||||||21.38|21.38|386.6884|66113.0333|63.4345
new_0222_0497|MIRM|202008|202006|202006|||||||||||||||-7.8888||||4.8408|||0||2.3872||||||9|1.8092||||||||||||||||||||||||25.96|25.96|510.0246|69786.5667|104.5705
new_0222_0497|MIRM|202009|202009|202009|138.151|133.749||3.378||21.61|18.792|2.818||120.255|-135.968||||-5.2738||||4.0399|||0||2.4846||5.177|0.003|||9|2.1811|||25.1329|67|-0.86|25.2109||25.2109|||-0.86|-2.271|-0.0298||-84.019|||||5.732|-21.509|-21.506|0.237|19.36|19.36|342.3906|77332.8|91.5507
new_0222_0497|MIRM|202010|202009|202009|||||||||||||||-3.9444||||3.3019|||0||2.5819||||||9|2.4718||||||||||||||||||||||||17.59|17.59|309.7107|53696.3|112.2642
new_0222_0497|MIRM|202011|202009|202009|||||||||||||||-7.0301||||5.0149|||0||2.7558||||||9|2.6455||||||25.7169||||||||||||||||||21.63|21.63|422.5075|58947.7667|225.2427
new_0222_0497|MIRM|202012|202012|202012|236.35|231.82||3.242||68.769|18.462|50.307||172.095|-173.171||||-3.226||||3.021|||0||3.4167||3.151|0.003|||10|1.9911|||26.1123|68|-1.43|29.7765||29.7765|||-1.43|-84.916|-0.0058||-103.27|||||7.225|-37.201|-37.203|-0.167|19.54|19.54|442.0342|263864.3|-28.7928
new_0222_0497|MIRM|202101|202012|202012|||||||||||||||-3.5223||||3.1747|||0||2.1201||||||3|1.8675||||||30.1522||||||||||||||||||19.25|19.25|348.6098|239112.3333|0.6108
new_0222_0497|MIRM|202102|202012|202012|||||||||||||||-3.6033||||3.2168|||0||2.2355||||||6|2.2888||||||||||||||||||||||||18.78|18.78|334.4383|125886.3|11.0036
new_0222_0497|MIRM|202103|202103|202103|217.755|213.113||3.06||88.358|35.022|53.336||133.883|-223.703||||-4.012||||4.4705|||0||2.5961||5.658|0.003|||4|3.2088|||30.105|85|-1.68|30.1981||30.1981|||-1.6881|-6.994|-0.0053||-132.492|||||9.479|-50.527|-50.532|-3.232|18.99|18.99|345.8501|153740.7667|41.5714
new_0222_0497|MIRM|202104|202103|202103|||||||||||||||-3.976||||4.4446|||0||2.4722||||||4|3.7256||||||30.4534||||||||||||||||||19.27|19.27|373.5005|101092.6|15.6213
new_0222_0497|MIRM|202105|202103|202103|||||||||||||||-3.0249||||3.7622|||0||2.3333|||||||3.9091||||||||||||||||||||||||15.84|15.84|269.2689|68141.8333|-1.1947
new_0222_0497|MIRM|202106|202106|202106|228.366|223.851||2.885||151.931|29.028|122.903||95.737|-267.597||||-2.5192|1.2126|||5.4753||0|0||2.2227||5.38|0.003|||2|3.9798|||30.2747|120|-1.45|30.3172||30.3172||7.7116|-1.4193|-0.938|-0.0098||-153.135|||11||13.353|-43.883|-43.894|-4.696|17.5|17.5|319.8215|98387.5333|-11.1511
new_0222_0497|MIRM|202107|202106|202106|||||||||||||||-1.8211||||4.6059|||0||1.299||||||2|3.9757||||||30.5158||||||||||||||||||14.1|14.1|203.6215|83502.7|-32.4135
new_0222_0497|MIRM|202108|202106|202106|||||||||||||||-2.2818||||5.1796|||0||1.5132||||||2|3.9905||||||||||||||||||||||||16.25|16.25|272.0308|72760.5|-37.4037
new_0222_0497|MIRM|202109|202109|202109|196.805|190.034||2.724|19|178.771|50.387|128.384||56.396|-314.705||||-3.0577|1.7675|||10.74||0|0||1.5759|0.4|5.003|0.003|||2|1.9695|||30.3677|137|-1.55|30.4063||30.4063||3.7794|-1.5826|-0.345|-0.0151||-178.737|||5||17.353|-47.099|-47.108|-5.595|18.75|18.75|348.3202|251466.5667|3.3731
new_0222_0497|MIRM|202110|202109|202109|||||||||||||||-2.154||||8.5618|||0||1.4878||||||3|0.87||||||||||||||||||||||||15.8|15.8|290.3855|332432.1|-1.5499
new_0222_0497|MIRM|202111|202109|202109|||||||||||||||-1.8092||||7.7307|||0||1.3439||||||3|-2.1457||||||30.6382||||||||||||||||||14.23|14.23|245.9476|158148.6333|-39.3177
new_0222_0497|MIRM|202112|202112|202112|||||||||||||||-2.1969||||8.6651|||0||1.4756||||||2|-1.4469||||||||||||||||||||||||15.93|15.93|298.0325|135719.9|-8.6483
new_0222_0497|MIRM|202201|202112|202112|||||||||||||||-2.8956||||10.3493|||0||1.8666||||||4|-1.8598||||||||||||||||||||||||17.72|17.72|352.8749|161951.3|5.1325
new_0222_0497|MIRM|202202|202112|202112|||||||||||||||-3.7273||||12.468|||0|||||||||||||||||||||||||||||||||22.95|22.95|506.6787|189837.3|13.4731